| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |